Strategic Advisory
Positioning, market mapping, comparable transaction analysis, counterparty intelligence, and term-structure benchmarking — for clients preparing to run a process.
Senior advisory for global life sciences transactions.
Backed by proprietary intelligence.
Detroit · New York · Global Execution
The Practice
Peer-level deal counsel.
Full Deal Advisory
End-to-end transaction support: term sheet structuring, counterparty negotiation, deal architecture, and close coordination.
M&A / Licensing Execution
Full execution mandates for material transactions. Whole-company sale processes, buy-side mid-pharma, and cross-border execution — bulge-bracket-caliber work at mid-market scale.
Selected Work
Oncology·Phase 2 asset, ex-US territorial out-licensing to a top-10 pharma partner
Rare Disease·Global licensing engagement with milestone structure optimization
Cross-Border·China-originated clinical-stage platform, full M&A execution through close
Immunology·Buy-side target identification and acquisition support for mid-pharma
Intelligence Foundation
Built on verified data — not opinion.
A proprietary deal database sourced from SEC filings and FTC premerger notifications. A partner-matching dataset mapping counterparty activity across therapeutic areas. Four data platforms turning infrastructure into live intelligence — refreshed daily and refined through every mandate.
Every term we anchor, every counterparty we propose sits on this foundation.
2,500+Deal Database
850+Companies Tracked
12Therapeutic Areas
Bring us your transaction.
We’ll meet you at peer level — anywhere in the world.